This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

China Medical Technologies' CEO Discusses F2Q 2011 Results - Earnings Call Transcript

China Medical Technologies, Inc. (CMED)

F2Q 2011 (09/30/11) Earnings Conference Call

November 18, 2011 8:00 AM EST

Executives

Winnie Yam – IR

Charles Zhu – SVP, Operations

Sam Tsang – CFO

Xiaodong Wu – CEO

Analysts

Jack Hu – Deutsche Bank

Chris Lui – Morgan Stanley

Presentation

Operator

Thank you for standing by. Welcome to the second quarter 2011 China Medical Technologies’ earnings conference call.

At this time, all participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session. (Operator Instructions). I must advise you that this conference is being recorded today, November 18 th, 2011.

I would now like to hand the conference over to your speaker today, Ms. Winnie Yam. Please go ahead.

Winnie Yam

Good day, ladies and gentlemen. I am pleased to welcome you to China Medical earnings conference call. China Medical already announced its second fiscal quarter financial results ended September 30 th, 2011. A copy of the press release is also available on the company’s website at www.chinameditech.com.

Today, your speakers will be Mr. Xiaodong Wu, CEO; Mr. Sam Tsang, CFO; and Mr. Charles Zhu, Senior VP of Operations. After they finish with their remarks, they will be available to answer your question.

Before we continue, please bear with me as I take you through the company’s Safe Harbor policy. The discussion today will contain forward-looking statements made under the Safe Harbor Provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements involve inherent risk and uncertainty. As such, the results may be materially different from the views expressed today. A number of potential risk and uncertainties are outlined in the company’s public filings with the US Securities and Exchange Commission.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,127.29 +47.15 0.26%
S&P 500 2,122.07 +4.38 0.21%
NASDAQ 5,103.7760 +11.6910 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs